Mr. Rigby is the Group Chief Executive Officer of Revolo Biotherapeutics and has three decades of experience in the pharmaceutical and biotechnology industries SAN DIEGO and CALGARY, AB
/PRNewswire/ Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced the appointment of Jonathan Rigby to its Board of Directors. "Jonathan has.
How Women Lead Strengthens Board Bench With Powerful Appointments - portada-online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from portada-online.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ As per Zion Market Research study, The global needle-free diabetes care market size was worth USD 9.1 billion in 2021 and is estimated to grow.
/PRNewswire/ As per Zion Market Research study, The global epilepsy therapeutics market was valued at over $13 billion in 2021 and is likely to surpass.